Patent · US Expired

Composition for contraception

US5824667A · kind A · utility

13Cited by

0References

10Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Jurgen Spona · Wien, AT
Bernd Dusterberg · Berlin, DE
Frank Ludicke · Basel, CH

Key dates

Filing date	Oct 31, 1996
Grant date	Oct 20, 1998
Priority date	—
Expiry date	Oct 31, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination product for oral contraception is disclosed comprising an estrogen selected from PA1 2.0 to 6.0 mg of 17.beta.-estradiol and PA1 0.020 mg of ethinylestradiol; and a gestagen selected from PA1 0.25 to 0.30 mg of drospirenone and PA1 0.1 to 0.2 mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.